Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-06-001805
Filing Date
2006-07-18
Accepted
2006-07-18 17:06:48
Documents
1
Period of Report
2006-07-14

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 3023
  Complete submission text file 0001127602-06-001805.txt   4880
Mailing Address 41 PINELAWN ROAD MELVILLE NY 11747
Business Address 41 PINELAWN ROAD MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Issuer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address OSI PHARMACEUTICALS INC 58 S SERVICE RD STE 110 MELVILLE NY 11747
Business Address
GRANNER DARYL K (Reporting) CIK: 0001238974 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-15190 | Film No.: 06967638